Hylan G-F 20 Improves Hip Osteoarthritis: A Prospective, Randomized Study

References

• . Zhang W, Doherty M, Arden N, ; EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64(5):669–681
   PubMed Web of Science ®Google Scholar
• . Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage. 2005;13(9):769–781
   PubMed Web of Science ®Google Scholar
• . Dawson J, Linsell L, Zondervan K, . Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology. 2004;43(4):497–504
   PubMed Web of Science ®Google Scholar
• . Flanagan J, Casale FF, Thomas TL, Desai KB. Intra-articular injection for pain relief in patients awaiting hip replacement. Ann R Coll Surg Engl. 1988;70(3):156–157
   PubMed Web of Science ®Google Scholar
• . Plant MJ, Borg AA, Dziedzic K, Saklatvala J, Dawes PT. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis. 1997;56(8):476–480
   PubMedGoogle Scholar
• . Robinson P, Keenan AM, Conaghan PG. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology. 2007;46(2):285–291
   PubMedGoogle Scholar
• . Kullenberg B, Runesson R, Tuvhag R, Olsson C, Resch S. Intraarticular corticosteroid injection: pain relief in osteoarthritis of the hip? J Rheumatol. 2004;31(11):2265–2268
   PubMedGoogle Scholar
• . Lambert RG, Hutchings EJ, Grace MG, Jhangri GS, Conner-Spady B, Maksymowych WP. Steroid injection for osteoarthritis of the hip: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2007;56(7):2278–2287
   PubMedGoogle Scholar
• . Zhang W, Moskowitz RW, Nuki G, . OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162
   PubMed Web of Science ®Google Scholar
• . Synvisc [package insert]. Ridgefield, NJ: Genzyme Biosurgery; 2006
   Google Scholar
• . Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine. 2002;69:388–391
   PubMed Web of Science ®Google Scholar
• . Conrozier T, Bertin P, Mathieu P, . Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol. 2003;21(5):605–610
   PubMedGoogle Scholar
• . Tikiz C, Unlu Z, Sener A, Efe M, Tüzün C. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Clin Rheumatol. 2005;24(3):244–250
   PubMed Web of Science ®Google Scholar
• . Conrozier T, Bertin P, Bailleul F, . Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. Joint Bone Spine. 2006;73(6):705–709
   PubMed Web of Science ®Google Scholar
• . Koseoglu BF, Sutbeyaz ST, Sezer N, Hatipoglu C, Comert D. Efficacy and safety of ultrasound guided intra-articular injections of hylan G-F 20 in patients with hip osteoarthritis. Pain Clinic. 2005;17(4):395–400
   Google Scholar
• . Migliore A, Tormenta S, Martin Martin LS, . The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol. 2006;25(3):389–393
   PubMed Web of Science ®Google Scholar
• . Migliore A, Tormenta S, Massafra U, . Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin. 2008;24(5):1309–1316
   PubMed Web of Science ®Google Scholar
• . Caglar-Yagci H, Unsal S, Yagci I, Dulgeroglu D, Ozel S. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int. 2005;25:341–344
   PubMed Web of Science ®Google Scholar
• . Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res. 1994;55(3):319–330
   Google Scholar
• . Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol. 2004;22(3):300–306
   PubMed Web of Science ®Google Scholar
• . Migliore A, Tormenta S, Massafra U, . Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. Osteoarthritis Cartilage. 2005;13(12):1126–1127
   PubMed Web of Science ®Google Scholar
• . Pourbagher MA, Ozalay M, Pourbagher A. Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med. 2005;24(10):1391–1395
   PubMedGoogle Scholar
• . Conrozier T, Couris CM, Mathieu P, . Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg. 2009;129(6):843–848
   PubMedGoogle Scholar
• . Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage. 2006;14(2):163–170
   PubMedGoogle Scholar
• . Migliore A, Massafra U, Bizzi E, . Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix(R)) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11(6):R183
   PubMedGoogle Scholar
• . Richette P, Ravaud P, Conrozier T, . Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthritis Rheum. 2009;60(3):824–830
   PubMedGoogle Scholar
• . Altman R, Alarcón G, Appelrouth D, . The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34(5):505–514
   PubMed Web of Science ®Google Scholar
• . Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502
   PubMed Web of Science ®Google Scholar
• . Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840
   PubMed Web of Science ®Google Scholar
• . Angst F, Ewert T, Lehmann S, Aeschlimann A, Stucki G. The factor subdimensions of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) help to specify hip and knee osteoarthritis. A prospective evaluation and validation study. J Rheumatol. 2005;32(7):1324–1330
   PubMedGoogle Scholar
• . Siddiqui O, Hung HM, O'Neill R. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets. J Biopharm Stat. 2009;19(2):227–246
   PubMed Web of Science ®Google Scholar
• . Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Information Journal. 2008;42:303–319
   Web of Science ®Google Scholar
• . Rubin DM. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley and Sons, Inc; 1987
   Google Scholar
• . Pham T, Van Der Heijde D, Lassere M, ; OMERACT-OARSI. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria J Rheumatol. 2003;30(7):1648–1654
   PubMedGoogle Scholar
• . Pham T, Van Der Heijde D, Altman RD, . OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004;12(5):389–399
   PubMed Web of Science ®Google Scholar
• . Moore RA, Derry S, McQuay HJ. Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports. Arthritis Res Ther. 2008;10(3):R53
   PubMedGoogle Scholar
• . Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil. 2003;84(8):1224–1226
   PubMedGoogle Scholar
• . Tubach F, Baron G, Falissard B, . Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale. Ann Rheum Dis. 2005;64(1):75–79
   PubMedGoogle Scholar
• . Dworkin RH, Turk DC, Wyrwich KW, . Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121
   PubMed Web of Science ®Google Scholar
• . Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis. 2005;64(9):1263–1267
   PubMed Web of Science ®Google Scholar
• . Waddell DD, Bricker DC. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis. J Manag Care Pharm. 2007;13(2):113–121
   PubMed Web of Science ®Google Scholar